Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Marker, Biological”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Post-approval studies (Phase 4)Study completedNCT00351871
What this trial is testing

Influence of Marker of Insulin Resistance Upon Hepatitis C Virus (HCV) Treatment Responses to PEG Intron and Rebetol Therapy

Who this might be right for
Chronic Hepatitis C
Louisiana State University Health Sciences Center in New Orleans 400
Not applicableStudy completedNCT05559034
What this trial is testing

Brain Oxygenation Marker for Cognitive Function in Healthy Adults

Who this might be right for
Mental Fatigue
Société des Produits Nestlé (SPN) 37
Testing effectiveness (Phase 2)Study completedNCT06097663
What this trial is testing

Investigate the Efficacy, Safety, and Tolerability of DFV890 and MAS825 for Inflammatory Marker Reduction in Adult Participants With Coronary Heart Disease and Clonal Hematopoiesis of Indeterminate Potential (CHIP)

Who this might be right for
Coronary Heart DiseaseClonal Hematopoiesis of Indeterminate Potential (CHIP)
Novartis Pharmaceuticals 31
Not applicableStudy completedNCT00613158
What this trial is testing

Using Differences in Peripheral Blood Leukocyte Gene Expression to Determine Cardiovascular Disease Risk

Who this might be right for
AtherosclerosisCardiovascular Diseases
National Heart, Lung, and Blood Institute (NHLBI) 120
Not applicableStudy completedNCT02892565
What this trial is testing

Hypercoagulable Phenotype by Thrombinography (in Presence of C Protein Dynamic Inhibitory System)

Who this might be right for
Venous Thrombosis
Central Hospital, Nancy, France 122
Not applicableLooking for participantsNCT05217407
What this trial is testing

Marker Assisted Selective ThErapy in Rare Cancers: Knowledge Database Establishing registrY Asia

Who this might be right for
Rare Malignant Neoplasm
National Cancer Center, Japan 1,000
Not applicableStudy completedNCT01253252
What this trial is testing

Endoprosthesis Treatment Effects on Human Abdominal Aorta Aneurysms (AAA) Metabolic Activity

Who this might be right for
Abdominal Aortic Aneurysm
Central Hospital, Nancy, France 45
Not applicableWithdrawnNCT03618277
What this trial is testing

Identification of Biomarkers and Characterization of Melasma

Who this might be right for
Chloasma
Pierre Fabre Dermo Cosmetique
Not applicableLooking for participantsNCT06637709
What this trial is testing

Persistent Pain in Pharmacologically or Surgical Treated Osteoarthritis: Role of Mu-Limpho Marker

Who this might be right for
Chronic PainOsteo Arthritis Knee
IRCCS San Raffaele Roma 192
Not applicableEnded earlyNCT04632498
What this trial is testing

Investigating Biological Markers, Targets, and Intervention for Mood Disorders

Who this might be right for
Major Depressive DisorderDepressionStress
Vanderbilt University Medical Center 61
Not applicableStudy completedNCT00340899
What this trial is testing

Biological Markers of Disease in the Prediction of Preterm Delivery, Preeclampsia and Intra-Uterine Growth Retardation: A Longtitudinal Study

Who this might be right for
Prenatal CarePremature Birth
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) 19,134
Post-approval studies (Phase 4)Ended earlyNCT00930345
What this trial is testing

Biological, Pathological and Imagery Markers in the First-line Treatment of Metastatic Clear-cell Renal Cell Carcinoma

Who this might be right for
Metastatic Renal Cell Carcinoma
Assistance Publique - Hôpitaux de Paris 33
Not applicableUnknownNCT04105400
What this trial is testing

Procalcitonin in Diagnosis of Sepsis in Critically Ill Patient

Who this might be right for
Sepsis, Severe
Assiut University 80
Not applicableNot Yet RecruitingNCT07367711
What this trial is testing

The Influence of Chemotherapy on Position Sense

Who this might be right for
CIPN - Chemotherapy-Induced Peripheral NeuropathyChemotherapy-Induced Peripheral NeuropathyChemotherapy-Induced Peripheral Neuropathy in Breast Cancer
KU Leuven 145
Early research (Phase 1)Looking for participantsNCT05371132
What this trial is testing

Study to Evaluate CD8 PET Imaging as a Marker of Immune Response to Stereotactic Body Radiation Therapy (ELIXR)

Who this might be right for
Metastatic Malignant Solid NeoplasmLymphoma
City of Hope Medical Center 10
Testing effectiveness (Phase 2)Study completedNCT01354314
What this trial is testing

Study of Paroxetine and Fluconazole for the Treatment of HIV Associated Neurocognitive Disorder

Who this might be right for
HIV Associated Neurocognitive Disorder
Johns Hopkins University 45
Not applicableLooking for participantsNCT07444853
What this trial is testing

Improving the Prognosis for Cerebral Hemorrhage A Study of Clinical, Biological, and Imaging Markers

Who this might be right for
Intracerebral Hemorrhage (ICH)
University Hospital, Tours 10,000
Not applicableLooking for participantsNCT06912477
What this trial is testing

Endothelial Dysfunction for Prognosis In Patients With preeClampSia

Who this might be right for
Preeclampsia (PE)Hypertensive Disorder of Pregnancy
Heidelberg University 385
Not applicableStudy completedNCT00681681
What this trial is testing

Sex Differences in Vascular Markers of Stroke Risk

Who this might be right for
Stroke
Wake Forest University Health Sciences 117
Not applicableUnknownNCT05679544
What this trial is testing

Biological Signatures Resulting From Occupational Exposure to Complex Mixtures of PAHs

Who this might be right for
Metabolic DisturbanceProtein DeficiencyGenotoxicity
University Hospital, Grenoble 100
Next Page